The New Role of Omega-3 Fatty Acids in Reducing ASCVD Risk in Women: Expert Dialogue - a podcast by ReachMD

CME credits: 0.75

Valid until: 30-11-2021

Claim your CME credit at https://reachmd.com/programs/cme/the-new-role-of-omega-3-fatty-acids-in-reducing-ascvd-risk-in-women-expert-dialogue/11988/

The latest information and guideline updates that healthcare professionals need to know for their practice are included in the recent AHA/ACC/Multisociety Blood Cholesterol Guidelines. These guidelines also introduce female-specific risk enhancers to help assess cardiovascular risk in women and discuss several new options for lowering LDL-C. Also examined is the new treatment option available for those with elevated triglyceride levels at risk of ASCVD events. The results from the REDUCE-IT trial on icosapent ethyl have led to new FDA indications and updates to many guidelines that now incorporate its use for patients with a high risk of a serious event and an elevated triglyceride level. The key takeaway from this expert dialogue is that lipid management has been redefined.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD